Literature DB >> 23726282

A probable case of acquired toxoplasmosis presenting as pyrexia of unknown origin in an immunocompetent individual.

K P P Abhilash1, M K Roshine, K Vandana, G M Varghese.   

Abstract

Disseminated toxoplasmosis presenting as a prolonged febrile illness is rare in immunocompetent individuals. We report a probable case of acquired toxoplasmosis in an immunocompetent woman who presented with fever of 6 months duration with lymphadenopathy and splenomegaly. The diagnosis was confirmed by serology and the presence of Toxoplasma gondii tachyzoites on bone marrow aspirate. The patient was successfully treated with pyrimethamine plus clindamycin.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disseminated toxoplasmosis; Immunocompetent; PUO

Mesh:

Year:  2013        PMID: 23726282     DOI: 10.1016/j.ijid.2013.03.024

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  4 in total

Review 1.  Diagnosis of toxoplasmosis and typing of Toxoplasma gondii.

Authors:  Quan Liu; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2015-05-28       Impact factor: 3.876

Review 2.  Toxoplasmosis in Iran: A guide for general physicians working in the Iranian health network setting: A systematic review.

Authors:  Seyed Mohammad Alavi; Leila Alavi
Journal:  Caspian J Intern Med       Date:  2016

3.  Early diagnosis and successful treatment of acquired toxoplasmosis infectious retinochoroiditis: A case report.

Authors:  Xiaoli Lv; Pingping Yu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Development of High Resolution Melting Analysis as a Diagnostic Tool for Molecular Detection of Toxoplasma Infection in Pregnant Women and HIV Positive Cases.

Authors:  Ahmad Hosseini-Safa; Saeedeh Shojaee; Seyed Alireza Salami; Mehdi Mohebali; Sedigheh Hantoushzadeh; Parisa Mousavi; Seyed Ali Dehghan Manshadi; Hossein Keshavarz Valian
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.